2seventy bio, Inc. (NASDAQ: TSVT) reported Q1 EPS of $0.01, $0.18 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $22.94 million versus the consensus estimate of $13.96 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.